Registries vs. Randomized Clinical Trials

Characteristic Versus Randomized Controlled Clinical Trial (RCT)
Treatment
  • Evaluate care in real-world setting
Time Period/Duration
  • Long-term outcomes collected
Patients
  • Can involve large numbers of patients; "typical" patients seen in real-world setting
  • Limited inclusion/exclusion criteria
Methods
  • Do not require comparator/placebo; "typical" care
  • Open-label; no defined/mandated interventions or data collection
  • No random allocation of patients
Statistical Analysis and Data Collection
  • Hypothesis generating; no sample size calculation; focus on "generalizeability"/heterogeneous patients
Patient Consent and Ethics Review
  • Focus on handling of personal health information and not risk
Safety
  • Voluntary reporting of adverse events
  • Unsolicited (vs. solicited) adverse event collection

 

Clinical trial perspective   Rregistry persepctive
     
  • Limited number of subjects
  • Study subjects are homogeneous
  • Homogeneity among limited investigative sites
  • Tight inclusion/exclusion criteria
  • Limited information
  • Safety and efficacy data
  • Prospective
 
  • Unlimited number of subjects
  • Study subjects are heterogeneous
  • Heterogeneity among numerous investigative sites
  • All subjects on therapy / open view
  • Macro and micro level view
  • Safety and effectiveness data
  • Prospective or retrospective
     

Patient Registries represent a unique and powerful method for the collection of observational, epidemiologic, and clinical data whereby accelerating innovation, producing faster knowledge gains, improving awareness of patient outcomes, and providing a clearer understanding of a therapy's' impact on patients' quality of life.